AstraZeneca PLC (LON:AZN) has been assigned an average rating of “Hold” from the twenty-three analysts that are currently covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and twelve have assigned a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is GBX 5,158.84 ($67.85).

Several analysts recently issued reports on the company. Investec boosted their price target on AstraZeneca PLC from GBX 4,900 ($64.45) to GBX 5,500 ($72.34) and gave the company a “buy” rating in a research note on Monday, November 6th. J P Morgan Chase & Co set a GBX 4,200 ($55.24) price target on AstraZeneca PLC and gave the company a “neutral” rating in a research note on Wednesday, August 9th. Barclays PLC restated an “overweight” rating and issued a GBX 5,500 ($72.34) price target on shares of AstraZeneca PLC in a research note on Monday, August 7th. HSBC Holdings PLC boosted their price target on AstraZeneca PLC from GBX 4,340 ($57.08) to GBX 4,380 ($57.61) and gave the company a “reduce” rating in a research note on Thursday, November 16th. Finally, Jefferies Group LLC reduced their price target on AstraZeneca PLC from GBX 4,900 ($64.45) to GBX 4,400 ($57.87) and set a “hold” rating for the company in a research note on Tuesday, August 1st.

AstraZeneca PLC (LON AZN) opened at GBX 5,018 ($66.00) on Thursday. AstraZeneca PLC has a one year low of GBX 3,996 ($52.56) and a one year high of GBX 5,520 ($72.60).

WARNING: “AstraZeneca PLC (AZN) Given Average Rating of “Hold” by Analysts” was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/astrazeneca-plc-azn-given-average-rating-of-hold-by-analysts/1721068.html.

AstraZeneca PLC Company Profile

AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience.

Analyst Recommendations for AstraZeneca PLC (LON:AZN)

Receive News & Ratings for AstraZeneca PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.